The 8 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 410.00, with a high estimate of 460.00 and a low estimate of 325.00. The median estimate represents a +9.27% increase from the last price of 375.22.
The current consensus among 11 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.88
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.